Schultheiss H P, Klingenberg M
Eur J Biochem. 1984 Sep 17;143(3):599-605. doi: 10.1111/j.1432-1033.1984.tb08412.x.
Antibodies have been prepared against purified preparations of the heart and kidney nucleotide translocator in the 'c'-conformation. The results show organ-specific antigenic determinants on the translocator proteins isolated from heart, kidney and liver although a partial cross-reactivity between these three proteins was demonstrable. The organ specificity was observed both with the solubilized and with the membrane-bound translocator protein indicating organ-specific determinants on exposed regions of the carrier. An organ-specific inhibition of the nucleotide transport in heart mitochondria by the heart carboxyatractylate-protein antiserum leads to the conclusion that the organ specificity is at least partially conditioned by the binding site for the substrate and/or the closely linked gate of the carrier protein. Apart from the organ specificity the results also demonstrate a specificity of the antibodies for the translocational conformations of the carrier: the 'c'-conformation stabilized in the carboxyatractylate-protein complex and the 'm'-conformation present in the bongkrekate-protein complex. However, after denaturation of the carboxytraktylate-protein and bongkrekate-protein complexes the binding of the anti-(carboxyatractylate-protein) antiserum to both inhibitor-protein complexes was nearly identical. The conformation specificity was also expressed by the inhibition of the conformation transition from the 'c'- to the 'm'- state. This side-specific inhibition of the nucleotide transport and the identical binding activity of the carboxyatractylate-protein antiserum against the denatured carboxyatractylate-protein and bongkrekate-protein complexes suggested that the conformation-specific antigenic determinants are topographic surface regions which are determined by the chain folding.
已制备出针对处于“c”构象的心脏和肾脏核苷酸转运体纯化制剂的抗体。结果表明,从心脏、肾脏和肝脏分离出的转运体蛋白上存在器官特异性抗原决定簇,尽管这三种蛋白之间存在部分交叉反应性。在可溶性和膜结合转运体蛋白中均观察到器官特异性,这表明载体暴露区域存在器官特异性决定簇。心脏羧基阿曲库铵 - 蛋白抗血清对心脏线粒体中核苷酸转运的器官特异性抑制作用表明,器官特异性至少部分由底物结合位点和/或载体蛋白紧密相连的门控所决定。除了器官特异性外,结果还表明抗体对载体转运构象具有特异性:在羧基阿曲库铵 - 蛋白复合物中稳定的“c”构象和在邦克里尔酸 - 蛋白复合物中存在的“m”构象。然而,羧基阿曲库铵 - 蛋白和邦克里尔酸 - 蛋白复合物变性后,抗(羧基阿曲库铵 - 蛋白)抗血清与两种抑制剂 - 蛋白复合物的结合几乎相同。构象特异性还通过抑制从“c”态到“m”态的构象转变来体现。核苷酸转运的这种侧特异性抑制以及羧基阿曲库铵 - 蛋白抗血清对变性的羧基阿曲库铵 - 蛋白和邦克里尔酸 - 蛋白复合物的相同结合活性表明,构象特异性抗原决定簇是由链折叠决定的拓扑表面区域。